Key facts
- This page summarizes Ph.D. Robert Hershberg MD's Form 3 filing for DANAHER CORP /DE/ (DHR).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 16 Oct 2026, 17:00.
Ph.D. Robert Hershberg MD - 09 Oct 2026 Form 3 Insider Report for DANAHER CORP /DE/ (DHR)
- Reporting relationship
- Director
- Issuer ticker
- DHR
- Reported as of
- 09 Oct 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 16 Oct 2026, 17:00:20 UTC
- Prior SEC filing
- 07 Oct 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ James F. O'Reilly, attorney-in-fact for Robert Hershberg, MD, Ph.D.
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Ph.D. Robert Hershberg MD filed Form 3 for DANAHER CORP /DE/ (DHR) on 16 Oct 2026.
Change
- Previous filing in this sequence was filed on 07 Oct 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001274139
Primary reporting owner
HERSHBERG ROBERT
- Relationship
- Director
- Address
- 2200 PENNSYLVANIA AVE NW, SUITE 800W, WASHINGTON
- Signature
- /s/ James F. O'Reilly, attorney-in-fact for Robert Hershberg, MD, Ph.D.
- Signature date
- 16 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DHR
holding
No securities are beneficially owned
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 09 Oct 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit List: Ex. 24 - Power of Attorney